Applied DNA Sciences Inc. (NASDAQ: APDN) is 61.37% higher on its value in year-to-date trading and has touched a low of $3.61 and a high of $16.39 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The APDN stock was last observed hovering at around $7.27 in the last trading session, with the day’s gains setting it 0.96% off its average median price target of $18.00 for the next 12 months. It is also 65.71% off the consensus price target high of $24.00 offered by 3 analysts, but current levels are 41.21% higher than the price target low of $14.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $8.23, the stock is 1.41% and -12.26% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 9.32 million and changing 13.20% at the moment leaves the stock -0.77% off its SMA200. APDN registered 109.95% gain for a year compared to 6-month gain of 9.73%. The firm has a 50-day simple moving average (SMA 50) of $8.73 and a 200-day simple moving average (SMA200) of $8.07.
The stock witnessed a 5.24% loss in the last 1 month and extending the period to 3 months gives it a 51.29%, and is 15.92% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.27% over the week and 7.96% over the month.
Applied DNA Sciences Inc. (APDN) has around 59 employees, a market worth around $58.19M and $2.90M in sales. Distance from 52-week low is 127.98% and -49.79% from its 52-week high. The company has generated returns on investments over the last 12 months (-156.70%).
Applied DNA Sciences Inc. (APDN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Applied DNA Sciences Inc. (APDN) is a “Buy”. 3 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Applied DNA Sciences Inc. is expected to release its quarterly report on 08/16/2021 and quarterly earnings per share for the current quarter are estimated at -$0.24 with sales reaching $2.41M over the same period.The EPS is expected to grow by 65.70% this year, but quarterly earnings will post 542.20% year-over-year.
Applied DNA Sciences Inc. (APDN) Top Institutional Holders
26 institutions hold shares in Applied DNA Sciences Inc. (APDN), with 782.73k shares held by insiders accounting for 10.47% while institutional investors hold 28.91% of the company’s shares. The shares outstanding are 7.47M, and float is at 6.12M with Short Float at 5.89%. Institutions hold 25.89% of the Float.
The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 0.16 million shares valued at $0.8 million. The investor’s holdings represent 2.11% of the APDN Shares outstanding. As of Dec 30, 2020, the second largest holder is Blackrock Inc. with 87319.0 shares valued at $0.45 million to account for 1.17% of the shares outstanding. The other top investors are Creative Planning which holds 81145.0 shares representing 1.09% and valued at over $0.41 million, while Gsa Capital Partners Llp holds 0.49% of the shares totaling 36500.0 with a market value of $0.19 million.
Applied DNA Sciences Inc. (APDN) Insider Activity
A total of 7 insider transactions have happened at Applied DNA Sciences Inc. (APDN) in the last six months, with sales accounting for 5 and purchases happening 2 times. The most recent transaction is an insider sale by Anchin Scott L ,the company’sDirector. SEC filings show that Anchin Scott L sold 13,049 shares of the company’s common stock on Mar 10 at a price of $8.43 per share for a total of $0.11 million. Following the sale, the insider now owns 250.0 shares.
Applied DNA Sciences Inc. disclosed in a document filed with the SEC on Jun 26 that Montgomery William W (ex 5% owner) bought a total of 110,000 shares of the company’s common stock. The trade occurred on Jun 26 and was made at $5.25 per share for $0.58 million. Following the transaction, the insider now directly holds 0.24 million shares of the APDN stock.
Still, SEC filings show that on Jun 18, Montgomery William W (5% owner) acquired 40,000 shares at an average price of $5.25 for $0.21 million. The insider now directly holds 215,000 shares of Applied DNA Sciences Inc. (APDN).